OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Tourette syndrome is an inherited neuropsychiatric disorder characterized by sudden, rapid, recurrent, non-rhythmic motion or noise called tics. The early symptoms of TS are typically noticed first in childhood, with the average onset between the ages of 3 and 9 years. Approximately 10-15 percent of those affected have a progressive or disabling course that lasts into adulthood. Often, people with Tourette also have other conditions such as ADHD (attention deficit hyperactivity disorder), OCD (obsessive compulsive disorder) and ASD (autism spectrum disorder). It is estimated that Tourette’s affects up to 1% of population. It is 4-5 times more common in boys than in girls.
There is no cure for Tourette syndrome, it is a lifelong condition. Behavioral therapy, relaxation techniques and Deep brain stimulation are sufficient for many patients. Antipsychotic drugs (risperidone, ziprasidone, haloperidol etc) and Botulinum Toxin can reduce tics. Surgery is useful in extreme cases when the patient does not respond to all other forms of therapy. The Foundation Tourette is a non-profit organization that aims to raise awareness in close cooperation with the disease, its early detection and treatment options in Netherlands.